Transcutaneous CO2 monitoring in Paediatric Endoscopy
Not Applicable
Completed
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2020/09/027649
- Lead Sponsor
- Badal Parikh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 75
Inclusion Criteria
American Society of Anaesthesiologists Class I or II
Scheduled for endoscopic procedures
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary objective is to determine whether Transcutaneous CO2 monitoring <br/ ><br>in paediatric patients undergoing endoscopic procedures predicts severe hypoventilation <br/ ><br>Timepoint: Transcutaneous monitoring will be initiated 5 minutes before administration of sedative agents and continue until at least 10 minutes after final withdrawal of the endoscope
- Secondary Outcome Measures
Name Time Method Secondary objective is to assess the accuracy of Transcutaneous CO2 with PaCO2 in paediatric patientsTimepoint: Transcutaneous monitoring will be initiated 5 minutes before administration of sedative agents and continue until at least 10 minutes after final withdrawal of the endoscope